Nippon Express (Singapore) Receives IATA CEIV Pharma certification

KUALA LUMPUR, Feb 21 (Bernama) -- Nippon Express (Singapore) Pte Ltd (NX Singapore) has received IATA CEIV Pharma certification for its facility in the Free Trade Zone at Singapore Changi International Airport, effective Jan 17, 2023.

A group company of Nippon Express Holdings Inc, NX Singapore acquired Good Distribution Practice certification in October 2020, evidencing its compliance with internationally recognised standards for the proper distribution of pharmaceuticals.

“With the acquisition of CEIV Pharma certification, NX Singapore will now be able to provide safer and higher-quality pharmaceutical transportation and warehousing services using Singapore, an important hub for the pharmaceutical industry, as a nodal point,” it said in a statement.

The pharmaceutical/medical sector is one of Singapore's priority industries, which has seen remarkable growth, and many of the world's leading pharmaceutical companies have created an industrial cluster in Singapore by establishing research, development and manufacturing bases.

The Nippon Express Group has positioned the pharmaceutical industry as a key industry in its "Nippon Express Group Business Plan 2023 -- Dynamic Growth”, and is promoting the global development of a safe and secure pharmaceutical logistics platform to meet the ever more sophisticated and diverse needs of pharmaceutical logistics.

The group is committed to contributing to the health of people worldwide by supporting its customers in the global pharmaceutical industry through the establishment of a reliable and safe global pharmaceutical logistics platform.

-- BERNAMA